[STRUCTURAL AND FUNCTIONAL CHANGES MYOCARDIUM HYPERTENSIVE RATS IN APPLYING INDAPAMIDE AND ELLAGIC ACID].

Area of Science:

• Cardiovascular Pharmacology
• Cellular Biology
• Biochemistry

Context:

• Hypertension is a significant risk factor for cardiovascular disease.
• Myocardial damage is a common complication of sustained hypertension.
• Existing antihypertensive treatments may have limitations in addressing cardiac structural changes.

Purpose:

• To evaluate the combined antihypertensive efficacy of indapamide and ellagic acid.
• To investigate the impact of this combination on the structural integrity of the myocardium in a rat model of hypertension.
• To assess the effects on cardiomyocyte organelles and energy metabolism.

Summary:

• Experimental studies in hypertensive rats demonstrated that the combination of indapamide and ellagic acid significantly reduces blood pressure.
• The treatment mitigated structural damage to cardiomyocytes, including reduced degradation of contractile myofibrils, decreased mitochondrial lysis, and less cytoplasmic swelling.
• Combined administration of indapamide and ellagic acid promoted the normalization of myocardial energy metabolism and organelle function.

Impact:

• This research highlights a potential synergistic effect of indapamide and ellagic acid in managing hypertension-induced cardiac remodeling.
• The findings suggest a novel therapeutic strategy for protecting the myocardium in hypertensive individuals.
• Understanding the cellular mechanisms provides a basis for developing more effective cardiovascular therapies.